Danielle Savre Maya Bishop 43 episodes, Miguel Sandoval Pruitt Lindy Craine 2 episodes, Sean Francis Learn more More Like This. Kollek, M, MГјller, A, Egle, A, Erlacher, M. P, Stegelmann, F, Kneba, M, Schafhausen, P, Saussele, S, Frank, O, Larson, RA, Saglio, G, Michael Huemer, MSc. Weil mir Michael Stipe in den Hintern getreten hat. kulturnews: Wie bitte вЂ¦? Hiili Hiilesmaa, Frank Bornemann), Aufnahmen in Los Angeles, Finnland und Martina Gedeck, Ina MГјller, Ulrich Tukur oder Katharina Thalbach lesen die.
Category: stream seiten filmeTucuman, Fundacion Miguel Lillo, Universidad Nacional de 2ter Teil Verlag Karl MГјller GmbH, good / goed Book with dust. Danielle Savre Maya Bishop 43 episodes, Miguel Sandoval Pruitt Lindy Craine 2 episodes, Sean Francis Learn more More Like This. francioli (1) francis (50) francisco (14) francissen (1) franck (24) franinoviж (2) frank () franks (18) micelli (1) michael () miguel (10) miguet (5).
Miguel MГјller Frank Contribute to This Page VideoArabische Pferde Miguel Frank zirkusPferdedressur
Wenn Miguel MГјller Frank einem Studiocity gelingt, das, das bereits seit Jahrzehnten Sieger Kundendienst auf der ganzen Welt Гberzeugt - das ist das Miguel MГјller Frank Casino. - Deutsches KaiserreichSooner these should be raw, unrestricted and impure buy mg neurontin with mastercard treatment diffusion.
J Neurooncol. Novel therapeutic options in anaplastic large cell lymphoma: molecular targets and immunological tools. Merkel O, Hamacher F, Sifft E, Kenner L, Greil R Mol Cancer Ther.
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
Early Breast Cancer Trialists' Collaborative Group EBCTCG , Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R.
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.
Epub Aug 18 View this publication in the PUBMED database. Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.
Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer.
Effect of radiotherapy after breast-conserving surgery on year recurrence and year breast cancer death: meta-analysis of individual patient data for 10, women in 17 randomised trials.
Early Breast Cancer Trialists' Collaborative Group EBCTCG , Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R.
Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial Gastric-2 of the Arbeitsgemeinschaft Medikamentose Tumortherapie AGMT.
ASH Report. Novel agents in diffuse large B-cell lymphoma: A short update including ASH Melchardt T, Hofbauer SW, Greil R, Hopfinger G.
Clonal Diversity of the T Cell Repertoire Predicts Disease Progression in Chronic Lymphocytic Leukaemia Holler, C, Zaborsky, N, Hofbauer, JP, Kocher, T, Trapin, D, Asslaber, D, Greil, R, Egle, A BLOOD.
Tumor load reduction and prolongation of overall-survival by actinomycin D in a murine model of high-risk chronic lymphocytic leukemia Wacht, N, Sifft, E, Melchardt, T, Hamacher, F, Denk, U, Pinon-Hofbauer, J, Egle, A, Kocher, T, Steurer, M, Greil, R, Merkel, O ONKOLOGIE.
Activity of Azacitidine in 26 Unselected, Consecutive CMML Patients Included in the Austrian Azacitidine Registry AAR of the AGMT-Study Group Pleyer, L, Stauder, R, Burgstaller, S, Schreder, M, Tinchon, C, Pfeilstocker, M, Steinkirchner, S, Melchardt, T, Mitrovic, M, Girschikofsky, M, Lang, A, Krippl, P, Egle, A, Sliwa, T, Linkesch, W, Fridrik, MA, Greil, R BLOOD.
Treatment of invasive aspergillosis in cancer patients. Auberger, J, Russ, G, Greil, R, Egle, A, memo - Magazine of European Medical Oncology.
Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia. Weiss L, Melchardt T, Egle A, Grabmer C, Greil R, Tinhofer I.
Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL.
Hofbauer JP, Heyder C, Denk U, Kocher T, Holler C, Trapin D, Asslaber D, Tinhofer I, Greil R, Egle A. Raltegravir in pregnancy: a case series presentation.
Taylor N, Touzeau V, Geit M, Gisinger M, Egle A, Greil R, Rieger A, Zangerle R. Int J STD AIDS. Weiss L, Melchardt T, Neureiter D, Kemmerling R, Moshir S, Pleyer L, Greil R, Egle A.
Epub Jul 5. CDhyaluronan interactions in the pathophysiology of chronic lymphocytic leukemia - regulation by cell activation Girbl, T, Asslaber, D, Brachtl, G, Denk, U, Weiss, L, Naor, D, Greil, R, Hartmann, TN ONKOLOGIE.
Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.
Brachtl G, Sahakyan K, Denk U, Girbl T, Alinger B, Hofbauer SW, Neureiter D, Hofbauer JP, Egle A, Greil R, Hartmann TN. Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.
Gassner FJ, Weiss L, Geisberger R, Hofbauer JP, Egle A, Hartmann TN, Greil R, Tinhofer I. Cancer Immunol Immunother. Riding the 2-edged sword.
Egle A. Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Labi V, Erlacher M, Krumschnabel G, Manzl C, Tzankov A, Pinon J, Egle A, Villunger A.
Genes Dev. CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.
Leick M, Catusse J, Follo M, Nibbs RJ, Hartmann TN, Veelken H, Burger M. Epub Dec 2. Hartmann TN. JATROS Haematologie und Onkologie.
Is Liposome Encapsulated Doxorubicin Able to Reduce the Cardiotoxicity of Doxorubicin In the Treatment of DLBCL? A Randomised Study by the Austrian Working Party of Medical Oncology AGMT-Study NHL Fridrik, M, Petzer, AL, Keil, F, Willenbacher, W, Jager, U, Lang, A, Andel, J, Krieger, O, Oberaigner, W, Greil, R BLOOD.
Dose-Escalation with BEACOPP Escalated Is Superior to ABVD In the Combined-Modality Treatment of Early Unfavorable Hodgkin Lymphoma: Final Analysis of the German Hodgkin Study Group GHSG HD14 Trial Engert, A, Borchmann, P, Pluetschow, A, von Tresckow, B, Markova, J, Hitz, F, Kral, Z, Greil, R, Topp, MS, Villalobos, M, Zijlstra, JM, Soekler, M, Stein, H, Eich, HT, Mueller, RP, Fuchs, M, Diehl, V BLOOD.
Independent prognostic factors for response: updated results of the ABCSG study evaluating the addition of capecitabine to epirubicin-docetaxel neoadjuvant therapy for early breast cancer EBC Steger, GG, Greil, R, Jakesz, R, Lang, A, Mlineritsch, B, Rudas, M, Marth, C, Stoeger, H, Singer, CF, Gnant, M EJC SUPPL.
Targeting Pim-2, a novel survival protein of myeloma cells, kills malignant plasma cells Johrer, K, Obkircher, M, Neureiter, D, Parteli, J, Hamacher, F, Merkel, O, Wacht, N, Zidorn, C, Scheideler, M, Greil, R ONKOLOGIE.
Antiapoptotic effects of p21 in arsenic trioxide induced apoptosis in CLL Sifft, E, Asslaber, D, Schweiggl, S, Hamacher, F, Greil, R, Merkel, O ONKOLOGIE.
Non-pegylated liposomal doxorubicin in metastatic breast cancer MBC - Results from an Austrian post marketing surveillance programme Steger, GG, Mlineritsch, B, Bartsch, R, Pluschnig, U, Petru, E, Peintinger, F, Sevelda, P, Greil, R ONKOLOGIE.
Essential Thrombocythemia ET. Pleyer, L, Faber, V, Neureiter, D, Greil, R In: Greil, R, Pleyer, L, Neureiter, D, Faber, V Ed.
Chronic Myeloid Neoplasias and Clonal Overlap Syndromes.. Pleyer, L, Greil, R, In: Greil, R, Pleyer, L, Neureiter, D, Faber, V Ed. Clonal Bone Marrow Failure Overlap Syndromes.
Pleyer, L, Neureiter, D, Faber, V, Greil, R, In: Greil, R, Pleyer, L, Neureiter, D, Faber, V Ed. Primary Myelofibrosis PMF [Previously Chronic Idiopathic Mylofibrosis CIMF , Myelofibrosis with Myeloid Metaplasia MMM , Agnogenic Myeloid Metaplasia AMM ].
Pleyer, L, Faber, V, Neureiter, D, Greil, R, In: Greil, R, Pleyer, L, Neureiter, D, Faber, V Ed. De novo 'Classic' Paroxysmal Nocturnal Hemoglobinuria PNH Marchiafava-Micheli Syndrome.
Bewegung und Krebs. Pleyer, L, Kappacher, A, Rosenlechner, S, Greil, R, In: Braumann, KM, Stiller, N Ed. Bewegungstherapie bei internistischen Erkrankungen..
Polycythemia Vera PV. Pleyer, L, Neureiter, D, Greil, R, In: Greil, R, Pleyer, L, Neureiter, D, Faber, V Ed. Myelodysplastic Syndromes MDS.
Chronic Myelomonocytic Leukemia CMML. Rare Clonal Myeloid Diseases Melchardt T, Weiss L, Pleyer L, Neureiter D, Faber V, Greil R. In Greil R. Editors , Chronic Myeloid Neoplasias and Clonal Overlap Syndromes.
Wien New York: Springer , Springer, ISBN Chronic Myeloid Neoplasias and Clonal Overlap Syndromes. Greil, R, Pleyer, L, Neureiter, D, Faber, V, Triple negative breast cancer Ressler S.
Mlineritsch B Greil R memo - Magazine of European Medical Oncology. Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma. Fridrik MA, Hausmaninger H, Lang A, Drach J, Krieger O, Geissler D, Michlmayr G, Ulsperger E, Chott A, Oberaigner W, Greil R.
Wasim M, Carlet M, Mansha M, Greil R, Ploner C, Trockenbacher A, Rainer J, Kofler R. J Steroid Biochem Mol Biol. Epub May 6.
Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories.
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. Saglio G, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, Gallagher N, Hoenekopp A, Dong M, Haque A, Larson RA, Kantarjian HM N Engl J Med.
Evidence for the conversion of docetaxel into 7'-epidocetaxel in patients receiving Taxotere-based conventional chemotherapy.
Czejka M, Greil R, Ulsperger E, Schnait H, Kienesberger K, Brumnik T, Farkouh A, Schierholz J. Int J Clin Pharmacol Ther. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
Merkel O, Hamacher F, Laimer D, Sifft E, Trajanoski Z, Scheideler M, Egger G, Hassler MR, Thallinger C, Schmatz A, Turner SD, Greil R, Kenner L.
Proc Natl Acad Sci U S A. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study.
Michlmayr A, Bachleitner-Hofmann T, Baumann S, Marchetti-Deschmann M, Rech-Weichselbraun I, Burghuber C, Pluschnig U, Bartsch R, Graf A, Greil R, Allmaier G, Steger G, Gnant M, Bergmann M, Oehler R.
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. Early Breast Cancer Trialists' Collaborative Group EBCTCG , Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, Peto R, Bijker N, Solin L, Darby S.
J Natl Cancer Inst Monogr. Neue Therapie in Sicht. Merkel O, Kenner L, Greil R SpringerMedizin. Enzastaurin kills human CLL cells regardless of clinical risk profile, but fails to prolong life in a murine CLL model Kocher, T, Pinon, HJ, Holler, C, Denk, U, Greil, R, Egle, A ONKOLOGIE.
Interdependent regulation of p53 and miRa in chronic lymphocytic leukemia. Cell Cycle. An uncommon cause of anaemia: Sheehan's syndrome.
Melchardt T, Namberger K, Weiss L, Egle A, Faber V, Greil R. Epub Dec 7. MicroRNAs as biomarkers for the diagnosis and prognosis of human cancer.
Asslaber D, Pinon Hofbauer J, Greil R, Egle A. Journal of Nucleic Acids Investigations. Inhibition of GLI, but not Smoothened induces apoptosis in chronic lymphocytic leukemia cells.
Desch P, Asslaber D, Kern D, Schnidar H, Mangelberger D, Alinger B, Stoecher M, Hofbauer SW, Neureiter D, Tinhofer I, Aberger F, Hartmann TN, Greil R.
Modifying akt signaling in B-cell chronic lymphocytic leukemia cells. Int J Antimicrob Agents. The role of the VLA-4 integrin in adhesion and survival of chronic lymphocytic leukemia CLL cells Sahakyan, K, Hofbauer, S, Brachtl, G, Girbl, T, Henschler, R, Greil, R, Hartmann, TN ONKOLOGIE.
VLA-4 and CD38 in chronic lymphocytic leukemia - more than prognostic markers? Brechtl, G, Denk, U, Pinon-Hofbauer, JD, Greil, R, Hartmann, TN ONKOLOGIE.
Neoadjuvant chemoradiation therapy with capecitabine X plus cetuximab C , and external beam radiotherapy RT in locally advanced rectal cancer LARC : ABCSG trial R03 Eisterer, WM, De Vries, A, Oefner, D, Greil, R, Rabl, H, Tschmelitsch, J, Schmid, R, Kapp, K, Zehentmayr, F, Thaler, J J CLIN ONCOL.
Number needed to treat NNT as a drug efficacy measure: Zoledronic acid ZOL for early hormone-responsive breast cancer in the ABCSG trial Gnant, M, Mlineritsch, B, Schippinger, W, Luschin-Ebengreuth, G, Steger, G, Bjelic-Radisic, V, Jakesz, R, Kubista, E, Marth, C, Greil, R BREAST.
The number needed to treat NNT as a measure of drug efficacy: the case of zoledronic acid for early hormone-responsive breast cancer in the ABCSG trial Gnant, M, Mlineritsch, B, Schippinger, W, Luschin-Ebengreuth, G, Steger, G, Bjelic-Radisic, V, Jakesz, R, Kubista, E, Marth, C, Greil, R CANCER RES.
Goetz, M, Ames, M, Gnant, M, Filpits, M, Jakesz, R, Greil, R, Marth, C, Samonigg, H, Suman, V, Safgren, S, Kuffel, M, Weinshilboum, R, Erlander, M, Ma, XJ, Ingle, J CANCER RES.
A randomized phase III study comparing epirubicin, docetaxel, and capecitabine EDC to epirubicin and docetaxel ED as neoadjuvant treatment for early breast cancer - first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 ABCSG Steger, GG, Greil, R, Jakesz, R, Lang, A, Mlineritsch, B, Melbinger-Zeinitzer, E, Martin, C, Samonigg, H, Kubista, E, Gnant, M EJC SUPPL.
RESULTS FROM AN PHASE II STUDY Ludwig, H, Adam, Z, Greil, R, Tothova, E, Keil, F, Zojer, N, Thaler, J, Gisslinger, H, Egyed, M, Lang, A HAEMATOL-HEMATOL J.
The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.
Cancer Lett. Hodgkin lymphoma in Tyrol-a population-based study. Fong D, Steurer M, Greil R, Gunsilius E, Spizzo G, Gastl G, Tzankov A.
Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma. Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
Mlineritsch B, Schabel-Moser R, Andel J, Fridrik M, Moik M, Mayer P, Russ G, Rass C, Greil R Onkologie. Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Erratum in: N Engl J Med. Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.
Tinhofer I, Weiss L, Gassner F, Rubenzer G, Holler C, Greil R. J Immunother. Greil R, Moik M, Reitsamer R, Ressler S, Stoll M, Namberger K, Menzel C, Mlineritsch B.
Eur J Surg Oncol. Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.
Baselga J, Semiglazov V, van Dam P, Manikhas A, Bellet M, Mayordomo J, Campone M, Kubista E, Greil R, Bianchi G, Steinseifer J, Molloy B, Tokaji E, Gardner H, Phillips P, Stumm M, Lane HA, Dixon JM, Jonat W, Rugo HS.
Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit? Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.
Filipits M, Rudas M, Heinzl H, Jakesz R, Kubista E, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Nader A, Stierer M, Gnant MF Clin Cancer Res.
Epub Sep 1. Vincristine, idarubicin dexamethasone and thalidomide in scleromyxoedema. Laimer M, Namberger K, Massone C, Koller J, Emberger M, Pleyer L, Hintner H, Greil R.
Acta Derm Venereol. The Dark Side of the Moon - the Side Effects of Therapy in a Dynamic Era of Breast Cancer Management.
Greil R. The Inverse Correlation of Regulatory T Cells and Time to Initial Treatment in Chronic Lymphocytic B-Cell Leukemia Weiss, L, Melchardt, T, Grabmer, C, Egle, A, Tinhofer, I, Greil, R BLOOD.
PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia.
Initial evaluation of the Roche COBAS TaqMan HIV-1 v2. Taylor N, Schmid I, Egle A, Greil R, Patsch W, Oberkofler H. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
Hartmann TN, Grabovsky V, Wang W, Desch P, Rubenzer G, Wollner S, Binsky I, Vallon-Eberhard A, Sapoznikov A, Burger M, Shachar I, Haran M, Honczarenko M, Greil R, Alon R.
Molecular and cellular mechanisms of CLL: novel therapeutic approaches. Pleyer L, Egle A, Hartmann TN, Greil R. Nat Rev Clin Oncol.
Epub Jun 2. Novel therapeutics approaches to chronic lymphocytic leukemia based on recent biological insights.
Ogden, Zhexing Wen, Xuyu Qian, Yujing Li, Bing Yao, Jaehoon Shin, Feiran Zhang, Emily M. Lee, Kimberly M. Christian, Ruth A. Didier, Peng Jin, Hongjun Song, Guo-li Ming.
Tomasz J. Nowakowski, Alex A. Pollen, Elizabeth Di Lullo, Carmen Sandoval-Espinosa, Marina Bershteyn, Arnold R. Epelboin, M. Douine, G. Carles, N.
Villemant, M. Nacher, D. Rousset, F. Djossou, E. Jorge E Machado-Alba, Manuel E Machado-Duque, Andres Gaviria-Mendoza, Viviana A Orozco-Giraldo.
Jornal de Pediatria 92 :3, CrossRef. Cynthia G. Kaplan, Michael H. Covinsky, Debra S. Pediatric and Developmental Pathology 19 :3, CrossRef.
Gubio C. Campos, Silvia I. Sardi, Manoel Sarno, Carlos Brites. The Brazilian Journal of Infectious Diseases 20 :3, CrossRef. Fernanda P.
Silveira, Silvia V. The Journal of Heart and Lung Transplantation 35 :5, CrossRef. Lianpan Dai, Jian Song, Xishan Lu, Yong-Qiang Deng, Abednego Moki Musyoki, Huijun Cheng, Yanfang Zhang, Yuan Yuan, Hao Song, Joel Haywood, Haixia Xiao, Jinghua Yan, Yi Shi, Cheng-Feng Qin, Jianxun Qi, George F.
Avraham Bayer, Nicholas J. Lennemann, Yingshi Ouyang, John C. Bramley, Stefanie Morosky, Ernesto Torres De Azeved Marques, Sara Cherry, Yoel Sadovsky, Carolyn B.
Helen M. Lazear, Jennifer Govero, Amber M. Smith, Derek J. Platt, Estefania Fernandez, Jonathan J. Lulan Wang, Stephanie G. Valderramos, Aiping Wu, Songying Ouyang, Chunfeng Li, Patricia Brasil, Myrna Bonaldo, Thomas Coates, Karin Nielsen-Saines, Taijiao Jiang, Roghiyh Aliyari, Genhong Cheng.
Xuyu Qian, Ha Nam Nguyen, Mingxi M. Song, Christopher Hadiono, Sarah C. Ogden, Christy Hammack, Bing Yao, Gregory R.
Hamersky, Fadi Jacob, Chun Zhong, Ki-jun Yoon, William Jeang, Li Lin, Yujing Li, Jai Thakor, Daniel A. Berg, Ce Zhang, Eunchai Kang, Michael Chickering, David Nauen, Cheng-Ying Ho, Zhexing Wen, Kimberly M.
Christian, Pei-Yong Shi, Brady J. Maher, Hao Wu, Peng Jin, Hengli Tang, Hongjun Song, Guo-li Ming. Cell :5, CrossRef.
Miner, Bin Cao, Jennifer Govero, Amber M. Smith, Estefania Fernandez, Omar H. Cabrera, Charise Garber, Michelle Noll, Robyn S.
Klein, Kevin K. Noguchi, Indira U. Mysorekar, Michael S. Keith Pardee, Alexander A. Green, Melissa K. Takahashi, Dana Braff, Guillaume Lambert, Jeong Wook Lee, Tom Ferrante, Duo Ma, Nina Donghia, Melina Fan, Nichole M.
Daringer, Irene Bosch, Dawn M. Dudley, David H. Ki Wook Yun. Pediatric Infection and Vaccine 23 :1, CrossRef. Sharoda Dasgupta, Sarah Reagan-Steiner, Dana Goodenough, Kate Russell, Mary Tanner, Lillianne Lewis, Emily E.
Petersen, Ann M. Morbidity and Mortality Weekly Report 65 , CrossRef. Baden, Lindsey R. Powers, Ann M. Carteaux, Guillaume.
Maquart, Marianne. Brun-Buisson, Christian. Leparc-Goffart, Isabelle. Mekontso Dessap, Armand. Frontiers in Microbiology 7 CrossRef. Hao Song, Jianxun Qi, Joel Haywood, Yi Shi, George F Gao.
Marcia C. Una oportunidad para mejorar la seguridad sanitaria global. Hui-Lan Chen, Ren-Bin Tang. Journal of the Chinese Medical Association 79 :4, CrossRef.
Samson Sai-Yin Wong, Rosana Wing-Shan Poon, Sally Cheuk-Ying Wong. Journal of the Formosan Medical Association :4, CrossRef. Yong-Qiang Deng, Hui Zhao, Xiao-Feng Li, Na-Na Zhang, Zhong-Yu Liu, Tao Jiang, Da-Yong Gu, Lei Shi, Jian-An He, Hong-Jiang Wang, Zhao-Zeng Sun, Qing Ye, Dong-Yang Xie, Wu-Chun Cao, Cheng-Feng Qin.
Science China Life Sciences 59 :4, CrossRef. Emily E. Petersen, Kara N. Polen, Dana Meaney-Delman, Sascha R. Ellington, Titilope Oduyebo, Amanda Cohn, Alexandra M.
Oster, Kate Russell, Jennifer F. Kawwass, Mateusz P. Karwowski, Ann M. Powers, Jeanne Bertolli, John T. Olson, Margaret A. Honein, Maria Rivera, Denise J.
Jamieson, Sonja A. Zhaoyang Wang, Peigang Wang, Jing An. Virologica Sinica 31 :2, CrossRef. Orlando Acosta.
Colombian Journal of Anesthesiology 44 :2, CrossRef. Raad Shakir. The Lancet Neurology 15 :4, CrossRef.
Mark R Schleiss. What if cytomegalovirus was transmitted by mosquitoes. Priya Sampathkumar, Joyce L. Mayo Clinic Proceedings 91 :4, CrossRef.
Jennifer J Adibi, Ernesto T A Marques, Abigail Cartus, Richard H Beigi. Jouannic, C. Morbidity and Mortality Weekly Report 65 CrossRef.
Morbidity and Mortality Weekly Report 65 :9, CrossRef. Rubin, Eric J. Greene, Michael F. Morbidity and Mortality Weekly Report 65 :9 CrossRef.
Consuelo Silva de Oliveira, Pedro Fernando da Costa Vasconcelos. International Journal of Clinical Practice 70 :3, CrossRef.
Jornal de Pediatria 92 :2, CrossRef. Mauricio L Barreto, Manoel Barral-Netto, Rodrigo Stabeli, Naomar Almeida-Filho, Pedro F C Vasconcelos, Mauro Teixeira, Paulo Buss, Paulo E Gadelha.
Wilmer E. Travel Medicine and Infectious Disease 14 :2, CrossRef. Katherine E. Fleming-Dutra, Jennifer M. Nelson, Marc Fischer, J. Erin Staples, Mateusz P.
Karwowski, Paul Mead, Julie Villanueva, Christina M. Renquist, Anna A. Minta, Denise J. Jamieson, Margaret A. Honein, Cynthia A.
Moore, Sonja A. Morbidity and Mortality Weekly Report 65 :7, CrossRef. Adrija Hajra, Dhrubajyoti Bandyopadhyay, ShyamalKumar Hajra.
North American Journal of Medical Sciences 8 :3, CrossRef. Kyeongah Nah, Kenji Mizumoto, Yuichiro Miyamatsu, Yohei Yasuda, Ryo Kinoshita, Hiroshi Nishiura.
PeerJ 4. Lawrence Broxmeyer, Refik Kanjhan. Modern Research in Inflammation 05 , CrossRef. Ruth Halsne. Tidsskrift for Den norske legeforening :9, CrossRef.
Health 08 , CrossRef. Hee Jung Yoon. Journal of the Korean Medical Association 59 :6, CrossRef. Pritika Ramharack, Mahmoud E. RSC Adv. Cristina Possas.
Epidemiology and Health Merrill Singer. Global Public Health. Jing Wu, Da-Yong Huang, Jun-Tao Ma, Ying-Hua Ma, Yi-Fei Hu.
Chinese Medical Journal , CrossRef. Occupational Diseases and Environmental Medicine 04 , CrossRef. Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies Luke E.
Taylor Amy L. Swerdfeger Guy D. The Whiteley-Martin Research Centre, Discipline of Surgery, The University of Sydney, Nepean Hospital, Level 3, Clinical Building, PO Box 63, Penrith , NSW, Australia Received 29 November Highlights There was no relationship between vaccination and autism OR: 0.
Abstract There has been enormous debate regarding the possibility of a link between childhood vaccinations and the subsequent development of autism.
Keywords Vaccine Vaccination Immunisation Autism Autism spectrum disorder Thimerosal Mercury Table 2. Evolutionary Psychology Evolutionary Psychology publishes original empirical research on human psychology and behavior that is guided by an evolutionary perspective.
Find out more about all the open special issues due to be published in Evolutionary Psychology, and submit your paper to be included More about this journal Most Most Read Most Cited Zika Virus Associated with Microcephaly Article Activity ZIKV, an emerging mosquito-borne flavivirus, was initially isolated from a rhesus monkey in the Zika forest in Uganda in Case Report In mid-October , a year-old previously healthy European woman came to the Department of Perinatology at the University Medical Center in Ljubljana, Slovenia, because of assumed fetal anomalies.
Methods Autopsy and Central Nervous System CNS Examination An autopsy of the fetus and placenta was performed 3 days after termination of the pregnancy, with an extensive sampling of all organs, placenta, and umbilical cord.
Indirect Immunofluorescence Paraffin-embedded sections of the fetal brain tissue and brain tissue of an autopsied man as a negative control were incubated with serum obtained from the mother of the fetus dilution, , followed by antihuman IgG antibodies labeled with fluorescein isothiocyanate FITC dilution, Microbiologic Investigation RNA was extracted from 10 mg of the placenta, lungs, heart, skin, spleen, thymus, liver, kidneys, and cerebral cortex with the use of a TRIzol Plus RNA purification kit Thermo Fisher Scientific.
Results Autopsy and Neuropathological Findings The fetal body weight was g 5th percentile , the length 42 cm 10th percentile , and the head circumference 26 cm 1st percentile.
Electron Microscopy Although analysis of the ultrathin sections of the brain showed poorly preserved brain tissue with ruptured and lysed cells, clusters of dense virus-like particles of approximately 50 nm in size were found in damaged cytoplasmic vesicles.
Microbiologic Investigation Positive results for ZIKV were obtained on RT-PCR assay only in the fetal brain sample, where 6. Discussion This case shows severe fetal brain injury associated with ZIKV infection with vertical transmission.
Barclay Davide Bigoni David E. Bock David E. Booher David E. Brandt David Ebrey Davide Buscaldi Davide Calvaresi David E. Carter David E. Chinitz Davide Chiumello Davide Ciucci David Eckersall David E.
Clark David E. Clarke Davide Comoretto David Eddie David Edelman David E. Dematthews Davide Deriu David Edge David Edgerton Davide Di Gennaro Davide Dionisi David Edmond David Edmonds David Edward Marcinko David Edwards David Edwin Pingree David E.
Eisner David E Elder David E. Elder David E. Elkins Soc Davide Fiscaletti David E. Fisher David E. Fishman David E.
Garland Davide Giovanni Papa Davide Giuriato David E. Golan David E Gray David E. Guest David E. Gussak David E. Hatch David E.
Hiebeler David E. Hoffman David Eimer David Einhorn David Eisenbud David E. James David E. Jones David E. Klemm David E. Kyvig David E. Laughlin David E.
Lewis David Eliezer David Elizandro David Ellgering David Elliott David Ellis David Ellwood David Ellyard David Emanuel Hoffman Davide Martino David Embick David E.
Mcadams David E Mcclean David E. Mccraw David E. Mcnabb Davide Michieletto David Emin David E. Mohrman Davide Moraschi David E. Morrison Iii David E.
Mulcahy David E. Murphy David Enders David E. Newton David England David Enoch David Enrich David E.
Nye Davide Orsi David E. Perry David E. Platt David E. Pollard David E. Polley David Epstein David E. Radcliffe David E. Reisner David Erik Nelson Davide.
Rizzato David E. Rowe David E. Rye David E Sadava David E. Sadava David E. Sahn David E. Scharff Davide Schiffer David E. Schoonover David E.
Schroeder David Escors Davide Scullino Davide Secchi David Eshel David E. Shi Davide Sivolella Davide Spallazzo David Espinet David Esseni David Estlund David E.
Sumner David E. Sutton David E. Swayne David Etheridge Devid David Etheridge Etheridge David E. Traul Davide Turcato David Eugene Smith Davide Vampa David E.
Vance David Evanier David Evans Davide Viaggi Davide Vigetti David E. Wellbery David E. Wesson David E.
Wilkins David E. Laidler David E. Sarna David E. Zimerman David FöRster David Fairer David Fallon David F. Anderson David Fanning David Farber David Farland David Farrell Krell David Farrusseng David F.
Bateman David F. Burg David F. Carr David F. Ciambrone David F. D'Alessandro David Fee David Feinleib David Feinstein David Feldman David Fergusson David Fernbach David Ferry David F.
Ford David F. Griffiths David F. Groebner David F. Hendry David F. Horrobin David Finkelhor David Firestone David Fisher David Fiske David Fitzgerald David Flanagan David F.
Lancy David Flannery David Fleet David Fleming David Fletcher David Flink David Floyd David Flynn David F Manlove David F.
Marley David F. Mazurek David F. Noble David Foenkinos David Folkenflik David Fontana David Ford David Forrest David Forsyth David Foskett David Foster Wallace David F.
Ostwald David Foulkes David Fouto David Fox David Fox David F. Parkhurst David F. Parmelee David F. Peelo David F.
Pelly David F. Pierre Jr David France David Francis Curran David Fraser David Frawley David Frayne David Frederick Ross David French David Frenkiel David Friedman David Friend David Frum David F.
Schmitz David F. Stroncek David F. Tolin David F. Tver David Fung David Furch David Gabai David Gadd David Gaines David Gale David Galef David Galens David Gamble David Game David G.
Anderson David G. Andrews David Gange David Gardner David Garduno Barrera David Garets David Garrow David Gates David Gauntlett David G. Aviv David Gaynes David G.
Barrie David G. Blanchflower David G Blumenkrantz David G. Bolgiano David G. Bromley David G. Burke David G. Carmichael David G.
Chandler David G. Chapple David G Collings David G. Collings David G. Costa David Geary David Gebler David Geiger David Gelles David Genecov David Gentilcore David George Gordon David George Haskell David George Surdam David Gero David Gethin John David G.
Gillam David G Gilmore David G. Greenhalgh David G. Gutierrez David G. Hebert David G. Hull David G. Hunter David Gibbings David Gibson David Gilbarg David Gilbert David Gill David Gillard David Gillen David Giller David Gillespie David Gilliam David Gillies David Gillota David Gilmartin David Gilmour David Ginley David G.
Scott David Gissen David G. Kleinbaum David Glasser David Glauser David Gledhill David Glen Mick David Glick David G. Luenberger David G Mcafee David G.
Morgan-Owen David G. Ostrow David Gottlieb David Gould David Govrin David Gower David Gowler David G. Peterson David Gradwell David Graeber David Graham David Grambs David Gramling David Grann David Grant David Gray David Grazian David Green David Greenberg David Greentree David Greenwood David Gregory David Greig David Grembowski David Greven David G.
Ries David Gries Auth. David Griffeath David Griffith David Griffiths David Grinspoon David Gromer David Groome David G.
Roskies David Grotto David Grove David Grubbs David Grusky David G. Schaeffer David G. Schrunk David G.
Simons David G. Smith David G. Stern David G. Taylor David G. Thomson Davidg. Tompkins David G. Tuerck David Gullette David G Ullman David G. Vermette David G.
Allen David Halliday David Hally David Halpern David H. Alpers David Halsey David Hambling David Hamilton David Hammond David Hanan David Hancock David Hanlon David Hann David Hannay David Hanson David Harap David Hardwick David Hardy David Harel David Harland Rousseau David Harmon David Harp David Harper David Harries David Harris David Harrison David Harte David Hartsough David Harvey David Haslam David Hassan David Hatherly David Haven Blake David Hawkes David Hay David Haynes David Haywood Young David H.
Bailey David H. Barlow David H. Bennett David H. Boal David H. Chestnut David H. Clark David H. Cropley David H. Darrow David Head David Healy David H.
Eberly David Hecker David Heffelfinger David Held David Heller David Hempleman-Adams David Hencke David Henig David Henley David Henry David Hepworth David Herbert Somerset Cranage David Herd David Herman David Herres David Herzog David H.
Evans David Hewitt David Hewson David Hey David H. Liu David H. Friedman David H. Hubel David Higgs David Hilborn David Hill David Hillier David Hilton David Hindley David Hinton David Hirsh David Hitchcock David H.
Jackson David H. Kim David H. Kirn David H. Laidlaw David H. Levy David H. Lyth David H. Murdoch David Ho David Hobbs David Hockney David Hodge David Hodgson David Hoffeld David Hoffman David Hoffmann David Holcman David Hollar David Hollenberg David Holmgren David Holston David Holton David Hone David Hooper David Hopkins David Hornung David Horowitz David Horrobin David Horsager David Horspool David Horton Smith David Houle David House David Howard David Howard Bain David Howard Davis David Howard Gelin David Howarth David Howden David Howell David H.
Owens David Howie David Howlett David Hows David H. Persing David H. Phillips David H. Ramirez David H. Richter David H.
Ringstrom David H. Rosenthal David H. Ross David H. Sandler David H. Sattinger David H Sharp David H. Sharp David Hsu David H.
Wong David Hu David Hucaby David Huddart David Huebert David Hugh Bunnell David Hui David Hulme David Hume David Hundt David Hunt David Hunter-Chester David Hurst Thomas David Hutchison David Huxley David H.
Weis David Hyman David Ian Gibson David Ian Starling David Ian Wimpenny David I. Bainbridge David I. Bernstein David Icke David I Cleland David I.
Cleland David Igler David I. Hanauer David I Harvie David I. Mostofsky David I. Olive David Ip David I. Robert Forrest Williams.
Larry T. Shepherd, Thomas J. Frederick Clarkson. PAM JOHNSON-BENNETT. Jacky Davis. Howard Koch, Julius J.
Barbara Rose. Bobby Rexrode. Pauline Correia Stonehill. Arthur Goldschmidt, Lawrence Davidson. Ian P. Howard, Brian J.
Valery M. Lewis S. Association of Science-Technology Centers. Eric Hayot. Corbel, Ghislaine, Association des auteurs de l'Ontario.
John Hollander. Pete Mitchell. Tony Zigmond. Adrienne Kollenberg. Sergio Troncoso. Edward A. Ted Smith. Ken Coffman.
Leo Braudy. Stewart Jay Brown. Bruce E. Monica Hughes, Jan Burchett, Sara Vogler, Alison Hawes, Paeony Lewis, Nikki Gamble, Thelma Page.
Betty Gilderdale. Jeffrey L. Douglas W. Woods, Jonathan Kanter. Rex Bernardo. Prentice- Hall, inc. Reader's Digest Association.
Allen J. Wood, Bruce F. Michael Ashley. Erika Goulden, Linda Goulden. Committee on Government Reform and Oversight. Subcommittee on Human Resources.
Christopher McIntosh. Yasunari Kawabata. Walker Percy. Tarek Mohamed Hassan, Jilin Ye. Rex Ever Found. Steve Fiffer.
Harvey Newcomb. Music edition. Kelly Leiter, Julian Harriss, Stanley Johnson. Maurine A. Fry, Jerry D. Harris, Margaret Early. Tom Loizos. Linda Lazarides.
Mihailo Crnobrnja. Kelsang Gyatso. Robert Redfern. John Stevens. Nancy Callan. Geoffrey Goodwin. Robert G. Terry O'Brien, John Fraser.
Luke Monahan, Ned Prendergast. Geshe Kelsang Gyatso. Tony L. Doherty, Terry Horne. Fast Language LLC. Matt Brown. Robert T. Anthony M. Marco Fantuzzi.
Wolf Kahn, Nicholas Delbanco, Ameringer McEnery Yohe Gallery. Farwind, Miriya. Gary Shaw, Jim Jenkinson. Harvey J.
Gonzalez, Lois Fein. John Schwieder, Cindy Kumle. Fabio Della Sala, Stefania D'Agostino. Ed Buegge. Peter Whiteley.
Barbara Jennings. Scott Westerfeld, Devin K. William J. Robert L. Boylestad, Louis Nashelsky. Marcia VanderWoude, Denise McGregor. Anthony Roland Collection of Film on Art.
Maureen S. Steinbruner, Governance Project Center for National Policy U. Employment Committee. Sabin, Isbn Cram Textbook Reviews, John R. Great Britain, Stationery Office, The, Great Britain.
Welsh Office. Martha Buskirk, Mignon Nixon. Paul Latham, Salvation Army. Congo and Angola Kinshasa Territory.
Getwell Church of Christ Memphis, Tenn. Kathy Etling. Great Britain, Stationery Office, The. William E. Berger, Graeme P. John E. McMurry, David E.
Ballantine, David S. Ballantine, Carl A. Hoeger, Virginia E. Henry Rider Haggard. Harry Emerson Fosdick. Deborah E. Kelly, Samuel B. Alan M.
Jennifer Seidl. Herbert George Wells. Heather Angelika Dooley. Richard G. Schroeder, Myrtle W. Jane Hill. Christopher Sandford.
Since ,. Thomas R. Frazier, John Morton Blum. Aaron I. Bartholomew Augustine Santamaria, Santamaria. Jim Fairbairn.
Robin Tulleners. Richard M. Two Studies on the Inspiredness of the Apographs. Robert J. National Safety Council. Janet Hansen. Rod Campbell.
Davidson, Dan. Jim Davis. William Kornblum. Graad Fiona Clitheroe, Francois Marais, Mariaan Viljoen, Agnes Rankoana. Sally Hobart Alexander.
Gary Woodfield. Cameron Dokey. Yumi Park. Steve Aylett. Garza: Hearing Before the Committee on Homeland Security and Governmental Affairs, United States Senate of the One Hundred Eleventh Congress, First Session : Nomination of Alexander G.
Garza to be Assistant Secretary and Chief Medical Officer, U. Department of Committee on Homeland Security and Governmental Affairs.
Catherine Merrick, Rebecca Day. Gaie Houston. Daniel Little. Robert Edwards. Fiona Watt. Laura Rothstein, Scott F. Great Britain, Great Britain. Statutory Instruments, Great Britain.
Scottish Office. Cheryl Robinson. Robert Appaluccio, Mark Vanzini. David Peace. Sarah Chapman. Dirk Bogarde. Dwijendra Tripathi.
Mavis Tofte. David R. Rheumatology: Current Research. HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer. Rinnerthaler, G; Gampenrieder, SP; Greil, R.
Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination.
Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine. Scheithauer, W; Putora, PM; Grunberger, B; Eisterer, W; Woll, E; Prager, G; Scha-berl-Moser, R; Greil, R; Glatzer, M.
Therap Adv Gastroenterol. Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.
Schlick, K; Magnes, T; Huemer, F; Ratzinger, L; Weiss, L; Pichler, M; Melchardt, T; Greil, R; Egle, A. Lignans and sesquiterpene lactones from Hypochaeris radicata subsp.
Shulha, O; Cicek, SS; Wangensteen, H; Kroes, J; Mader, M; Girreser, U; Sendker, J; Johrer, K; Greil, R; Schuhly, W; Mangoni, A; Grauso, L; van Thriel, C; Zidorn, C.
Randomized phase III study ADMYRE of plitidepsin in combination with dexa-methasone vs. Spicka, I; Ocio, EM; Oakervee, HE; Greil, R; Banh, RH; Huang, SY; DxxxRozario, JM; Dimopoulos, MA; Martinez, S; Extremera, S; Kahatt, C; Alfaro, V; Carella, AM; Meuleman, N; Hajek, R; Symeonidis, A; Min, CK; Cannell, P; Ludwig, H; Sonneveld, P; Mateos, MV.
Ann Hematol. Systemic treatment of metastatic breast cancer: SABCS Westphal, T; Gampenrieder, SP; Greil, R. MEMO-MAG EUR MED ONC. Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia.
Willenbacher, E; Johrer, K; Willenbacher, W; Flogel, B; Greil, R; Kircher, B. Epub Oct Cytotoxic Properties of Damiana Turnera diffusa Extracts and Constituents and A Validated Quantitative UHPLC-DAD Assay.
Willer, J; Johrer, K; Greil, R; Zidorn, C; Cicek, SS. Exome sequencing of the TCL1 mouse model for CLL reveals genetic hetero-geneity and dynamics during disease development.
Zaborsky, N; Gassner, FJ; Höpner, JP; Schubert, M; Hebenstreit, D; Stark, R; Assla-ber, D; Steiner, M; Geisberger, R; Greil, R; Egle, A. Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia.
Bolger, GT, Licollari, A, Tan, A, Greil, R, Pleyer, L, Vcelar, B, Majeed, M, Sordillo, P. Tissino, E, Benedetti, D, Herman, SEM, Ten Hacken, E, Ahn, IE, Chaffee, KG, Rossi, FM, Dal Bo, M, Bulian, P, Bomben, R, Bayer, E, Härzschel, A, Gutjahr, JC, Postorino, M, Santinelli, E, Ayed, A, Zaja, F, Chiarenza, A, Pozzato, G, Chigaev, A, Sklar, LA, Burger, JA, Ferrajoli, A, Shanafelt, TD, Wiestner, A, Del Poeta, G, Hartmann, TN, Gattei, V, Zucchetto, A.
J Exp Med. Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia. Gutjahr, JC, Szenes, E, Tschech, L, Asslaber, D, Schlederer, M, Roos, S, Yu, X, Girbl, T, Sternberg, C, Egle, A, Aberger, F, Alon, R, Kenner, L, Greil, R, Orian-Rousseau, V, Hartmann, TN.
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT Arbeitsgemeinschaft Medikamentöse Tumortherapie.
Huemer, F, Thaler, J, Piringer, G, Hackl, H, Pleyer, L, Hufnagl, C, Weiss, L, Greil, R. BMC Cancer. PET-guided treatment in patients with advanced-stage Hodgkins lymphoma HD18 : final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Borchmann, P, Goergen, H, Kobe, C, Lohri, A, Greil, R, Eichenauer, DA, Zijlstra, JM, Markova, J, Meissner, J, Feuring-Buske, M, Hüttmann, A, Dierlamm, J, Soekler, M, Beck, HJ, Willenbacher, W, Ludwig, WD, Pabst, T, Topp, MS, Hitz, F, Bentz, M, Keller, UB, Kühnhardt, D, Ostermann, H, Schmitz, N, Hertenstein, B, Aulitzky, W, Maschmeyer, G, Vieler, T, Eich, H, Baues, C, Stein, H, Fuchs, M, Kuhnert, G, Diehl, V, Dietlein, M, Engert, A.
Huemer, F, Weiss, L, Faber, V, Neureiter, D, Egle, A, Geissler, K, Voskova, D, Zebisch, A, Burgstaller, S, Pichler, A, Stauder, R, Sperr, W, Lang, A, Pfeilstöcker, M, Machherndl-Spandl, S, Stampfl, M, Greil, R, Pleyer, L.
Wien Klin Wochenschr. Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.
Melchardt, T, Magnes, T, Hufnagl, C, Thorner, AR, Ducar, M, Neureiter, D, Tränkenschuh, W, Klieser, E, Gaggl, A, Rösch, S, Rasp, G, Hartmann, TN, Pleyer, L, Rinnerthaler, G, Weiss, L, Greil, R, Egle, A.
Incidence and risk factors for relapses in HIV-associated non-Hodgkin-lymphoma as observed in the German HIV-related lymphoma cohort study.
Schommers, P, Gillor, D, Hentrich, M, Wyen, C, Wolf, T, Oette, M, Zoufaly, A, Wasmuth, JC, Bogner, JR, Müller, M, Esser, S, Schleicher, A, Jensen, B, Stoehr, A, Behrens, G, Schultze, A, Siehl, J, Thoden, J, Taylor, N, Hoffmann, C.
The multiple myeloma treatment landscape: international guideline recommendations and clinical practice in Europe. Cavo, M, Terpos, E, Bargay, J, Einsele, H, Cavet, J, Greil, R, de Wit, E.
Expert Rev Hematol. A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.
Piringer, G, Fridrik, M, Fridrik, A, Leiherer, A, Zabernigg, A, Greil, R, Eisterer, W, Tschmelitsch, J, Lang, A, Frantal, S, Burgstaller, S, Gnant, M, Thaler, J.
Support Care Cancer. Burgstaller, S, Stauder, R, Kuehr, T, Lang, A, Machherndl-Spandl, S, Mayrbaeurl, B, Noesslinger, T, Petzer, A, Valent, P, Greil, R, Thaler, J.
Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia. Gassner, FJ, Schubert, M, Rebhandl, S, Spandl, K, Zaborsky, N, Catakovic, K, Blaimer, S, Hebenstreit, D, Greil, R, Geisberger, R.
Mol Cancer Res. Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.
Domenyuk, V, Gatalica, Z, Santhanam, R, Wei, XX, Stark, A, Kennedy, P, Toussaint, B, Levenberg, S, Wang, J, Xiao, NQ, Greil, R, Rinnerthaler, G, Gampenrieder, SP, Heimberger, AB, Berry, DA, Barker, A, Quackenbush, J, Marshall, JL, Poste, G, Vacirca, JL, Vidal, GA, Schwartzberg, LS, Halbert, DD, Voss, A, Magee, D, Miglarese, MR, Famulok, M, Mayer, G, Spetzler, D.
Nat Commun. DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer. Gampenrieder, SP, Rinnerthaler, G, Hackl, H, Pulverer, W, Weinhaeusel, A, Ilic, S, Hufnagl, C, Hauser-Kronberger, C, Egle, A, Risch, A, Greil, R.
Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity. Wolf, M, Aglas, L, Twaroch, TE, Steiner, M, Huber, S, Hauser, M, Parigiani, MA, Hofer, H, Ebner, C, Bohle, B, Briza, P, Neubauer, A, Stolz, F, Wallner, M, Ferreira, F.
J Allergy Clin Immunol. Factor VII deficiency in major artery occlusion stroke. Pikija, S, Gampenrieder, SP, Millesi, K, Pilz, G, Weis, S, Mutzenbach, JS.
Am J Hematol. Bachmayer, S, Fastner, G, Vaszi, A, Iglseder, W, Kopp, P, Holzinger, J, Dinnewitzer, A, Rinnerthaler, G, Gampenrieder, SP, Emmanuel, K, Greil, R, Sedlmayer, F, Zehentmayr, F.
Strahlenther Onkol. Egle, A, Steurer, M, Melchardt, T, Weiss, L, Gassner, FJ, Zaborsky, N, Geisberger, R, Catakovic, K, Hartman, TN, Pleyer, L, Voskova, D, Thaler, J, Lang, A, Girschikofsky, M, Petzer, A, Greil, R.
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG trial. Paschka, P, Schlenk, RF, Weber, D, Benner, A, Bullinger, L, Heuser, M, Gaidzik, VI, Thol, F, Agrawal, M, Teleanu, V, Lubbert, M, Fiedler, W, Radsak, M, Krauter, J, Horst, HA, Greil, R, Mayer, K, Kundgen, A, Martens, U, Heil, G, Salih, HR, Hertenstein, B, Schwanen, C, Wulf, G, Lange, E, Pfreundschuh, M, Ringhoffer, M, Girschikofsky, M, Heinicke, T, Kraemer, D, Gohring, G, Ganser, A, Dohner, K, Dohner, H.
Greil, R, Greil-Ressler, S, Weiss, L, Schönlieb, C, Magnes, T, Radl, B, Bolger, GT, Vcelar, B, Sordillo, PP. Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.
Krauth, MT, Burgstaller, S, Buxhofer-Ausch, V, Gastl, G, Geissler, K, Keil, F, Krippl, P, Melchardt, T, Petzer, A, Rumpold, H, Sliwa, T, Wöhrer, S, Wölfler, A, Gisslinger, H.
Austrian recommendations for the management of polycythemia vera. Burgstaller, S, Buxhofer-Ausch, V, Sliwa, T, Beham-Schmid, C, Gastl, G, Geissler, K, Melchardt, T, Krauth, M, Krippl, P, Petzer, A, Rumpold, H, Wölfler, A, Gisslinger, H.
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
Sasse, S, Goergen, H, Plütschow, A, Böll, B, Eichenauer, DA, Fuchs, M, Behringer, K, Zijlstra, JM, Greil, R, Markova, J, Topp, MS, Meissner, J, Neubauer, A, Baues, C, Engert, A, Borchmann, P, von Tresckow, B.
Extensive leptomeningeal intracranial and spinal metastases in a patient with a supratentorial glioblastoma multiforme, IDH-wildtype: A case report.
Schwartz, C, Romagna, A, Machegger, L, Weiss, L, Huemer, F, Fastner, G, Kleindienst, W, Serge, W, Greil, R, Winkler, PA. World Neurosurg. Remission maintenance treatment options in chronic lymphocytic leukemia.
Egle, A, Pleyer, L, Melchardt, T, Hartmann, TN, Greil, R. Cancer Treat Rev. News from ASCO Balic, M, Dedic, N, De Mattos-Arruda, L, Gampenrieder, S.
BREAST CARE. Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG POSYTIVE Trial. Fitzal, F, Bjelic-Radisic, V, Knauer, M, Steger, G, Hubalek, M, Balic, M, Singer, C, Bartsch, R, Schrenk, P, Soelkner, L, Greil, R, Gnant, M.
Ann Surg. Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia.
Ball, B, Komrokji, RS, Ades, L, Sekeres, MA, DeZern, AE, Pleyer, L, Vey, N, Almeida, A, Germing, U, Cluzeau, T, Platzbecker, U, Gore, SD, Fenaux, P, Prebet, T.
BLOOD ADV. RNA Trans-Splicing Modulation via Antisense Molecule Interference. Rinnerthaler, G, Gampenrieder, SP, Petzer, A, Burgstaller, S, Fuchs, D, Rossmann, D, Balic, M, Egle, D, Rumpold, H, Singer, CF, Bartsch, R, Petru, E, Melchardt, T, Ulmer, H, Mlineritsch, B, Greil, R.
Asamer, E, Szkandera, J, Gibiser, P, Lembeck, AL, Stojakovic, T, Kornprat, P, Lackner, C, Winder, T, Schlick, K, Stoger, H, Gerger, A, Pichler, M, Stotz, M.
Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial.
Westphal, T, Rinnerthaler, G, Gampenrieder, SP, Niebauer, J, Thaler, J, Pfob, M, Fuchs, D, Riedmann, M, Mayr, B, Reich, B, Melchardt, T, Mlineritsch, B, Pleyer, L, Greil, R.
Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.
Huber, S, Lang, R, Steiner, M, Aglas, L, Ferreira, F, Wallner, M, Hawranek, T, Gadermaier, G. Clin Transl Allergy. Schlick, K, Magnes, T, Ratzinger, L, Jaud, B, Weiss, L, Melchardt, T, Greil, R, Egle, A.
PLoS One. Bolger, GT, Licollari, A, Tan, A, Greil, R, Vcelar, B, Greil-Ressler, S, Weiss, L, Schönlieb, C, Magnes, T, Radl, B, Majeed, M, Sordillo, PP.
ASCO highlights: metastatic breast cancer. Rinnerthaler, G, Gampenrieder, SP, Greil, R. T cell exhaustion: from pathophysiological basics to tumor immunotherapy.
Catakovic, K, Klieser, E, Neureiter, D, Geisberger, R. Cell Commun Signal. Aberger, F, Hutterer, E, Sternberg, C, Del Burgo, PJ, Hartmann, TN.
A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma. Kiesewetter, B, Willenbacher, E, Willenbacher, W, Egle, A, Neumeister, P, Voskova, D, Mayerhoefer, ME, Simonitsch-Klupp, I, Melchardt, T, Greil, R, Raderer, M.
Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.
Greil, R, Hutterer, E, Hartmann, TN, Pleyer, L. Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIVInfected Patients.
Taylor, N, Kremser, I, Auer, S, Hoermann, G, Greil, R, Haschke-Becher, E, Esterbauer, H, Kenner, L, Oberkofler, H. J Acquir Immune Defic Syndr.
The double-edged sword of re expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.
Wolff, F, Leisch, M, Greil, R, Risch, A, Pleyer, L. Ludwig, H, Weisel, K, Petrucci, MT, Leleu, X, Cafro, AM, Garderet, L, Leitgeb, C, Foa, R, Greil, R, Yakoub-Agha, I, Zboralski, D, Vauleon, S, Duemmler, T, Beyer, D, Kruschinski, A, Riecke, K, Baumann, M, Engelhardt, M.
Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial. Weiss, L, Melchardt, T, Egle, A, Hopfinger, G, Hackl, H, Greil, R, Barth, J, Rummel, M.
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group Pleyer, L, Dohner, H, Dombret, H, Seymour, JF, Schuh, AC, Beach, CL, Swern, AS, Burgstaller, S, Stauder, R, Girschikofsky, M, Sill, H, Schlick, K, Thaler, J, Halter, B, Spandl, SM, Zebisch, A, Pichler, A, Pfeilstocker, M, Autzinger, EM, Lang, A, Geissler, K, Voskova, D, Sperr, WR, Hojas, S, Rogulj, IM, Andel, J, Greil, R.
INT J MOL SCI. Egle, A. Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer, W, Piringer, G, De Vries, A, Ofner, D, Greil, R, Tschmelitsch, J, Samonigg, H, Solkner, L, Gnant, M, Thaler, J.
The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y. Auer, S, Rinnerthaler, M, Bischof, J, Streubel, MK, Breitenbach-Koller, H, Geisberger, R, Aigner, E, Cadamuro, J, Richter, K, Sopjani, M, Haschke-Becher, E, Felder, TK, Breitenbach, M.
Front Oncol. Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib. Kazianka, L, Drucker, C, Skrabs, C, Thomas, W, Melchardt, T, Struve, S, Bergmann, M, Staber, PB, Porpaczy, E, Einberger, C, Heinz, M, Hauswirth, A, Raderer, M, Pabinger, I, Thalhammer, R, Egle, A, Wendtner, CM, Follows, G, Hoermann, G, Quehenberger, P, Jilma, B, Jaeger, U.
Amb a 1 isoforms: unequal siblings with distinct immunological features. Wolf, M, Twaroch, TE, Huber, S, Reithofer, M, Steiner, M, Aglas, L, Hauser, M, Aloisi, I, Asam, C, Hofer, H, Parigiani, MA, Ebner, C, Bohle, B, Briza, P, Angela, N, Stolz, F, Jahn-Schmid, B, Wallner, M, Ferreira, F.
Clinical Outcomes of Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study Almeida, AM, Prebet, T, Itzykson, R, Ramos, F, Al-Ali, H, Shammo, J, Pinto, R, Maurillo, L, Wetzel, J, Musto, P, Van De Loosdrecht, AA, Costa, MJ, Esteves, S, Burgstaller, S, Stauder, R, Autzinger, EM, Lang, A, Krippl, P, Geissler, D, Falantes, JF, Pedro, C, Bargay, J, Deben, G, Garrido, A, Bonanad, S, Diez-Campelo, M, Thepot, S, Ades, L, Sperr, WR, Valent, P, Fenaux, P, Sekeres, MA, Greil, R, Pleyer, L.
Differences in stem cell processing lead to distinct secretomes secretion - implications for differential results of previous clinical trials of stem cell therapy for myocardial infarction.
Biotechnol J. The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes, T, Melchardt, T, Hufnagl, C, Weiss, L, Mittermair, C, Neureiter, D, Klieser, E, Rinnerthaler, G, Roesch, S, Gaggl, A, Greil, R, Egle, A.
Pharmacogenomics J. Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.
Magnes, T, Melchardt, T, Weiss, L, Mittermair, C, Neureiter, D, Klieser, E, Gampenrieder, S, Moser, G, Gaggl, A, Greil, R, Egle, A.
Auer, S, Rinnerthaler, M, Bischof, J, Streubel, MK, Breitenbach-Koller, H, Geisberger, R, Aigner, E, Cadamuro, J, Richter, K, Sopjani, M, Haschke-Becher, E, Felder, TK, Breitenbach, M, Front Oncol.
SABCS systemic therapy for metastatic breast cancer. Gampenrieder, SP, Rinnerthaler, G, Greil, R. Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R.
Red blood cell alloimmunization in patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience. Leisch, M, Weiss, L, Lindlbauer, N, Jungbauer, C, Egle, A, Rohde, E, Greil, R, Grabmer, C, Pleyer, L.
Leuk Res. Hainzl, S, Peking, P, Kocher, T, Murauer, EM, Larcher, F, Del Rio, M, Duarte, B, Steiner, M, Klausegger, A, Bauer, JW, Reichelt, J, Koller, U.
Mol Ther. Azacitidine in adult patients with acute myeloid leukemia. Schuh, AC, Dohner, H, Pleyer, L, Seymour, JF, Fenaux, P, Dombreth, H.
Crit Rev Oncol Hematol. Improvement of quality of life and psychological distress after inpatient cancer rehabilitation.
Riedl, D, Giesinger, JM, Wintner, LM, Loth, FL, Rumpold, G, Greil, R, Nickels, A, Licht, T, Holzner, B.
But rather than build coherent and smooth sovereign imaginations, the museum can be tasked with pulling apart these imaginations in an attempt to undo the logic of communion.
The District Six Museum in South Africa offers a key example of how such countermonumental practices can be exercised. This museum is actively engaged in the undoing of conceptions of community.
While the museum is committed to revisiting history in the hopes of building an anticapitalist and anti-apartheid South Africa, it is also wary of the dangers of too easily falling into simple conceptions of history and community.
This is particularly important for the staff as the landscapes of trauma and violence are layered with multiple and competing claims to land and history.
Therefore, they simultaneously launch programs that interrogate notions of community, home, and race while also attempting to build an anti-apartheid city.
I elaborate on these critical memorializing practices in detail in chapters 3 and 4. In sum, pairing the museum with the constitution affords two vital opportunities.
First, it decenters the constitution as the central tool in the production of political community. Second, the museum offers an external resource that can provide reflexive reconsiderations of community that the constitution cannot.
In its reflexive role, however, the museum is not intended to augment or add to the constitution. I am not calling for a radical dispersion of public life into privatized identity politics.
Rather, my concern is passionately invested in the public sphere, who and what we think it includes and how it is maintained.
Constitutions offer a supposedly universal method of communicating what the essential parts of our public is made up of, what basic tenets we can all agree to.
But what do we do with those humans, nonhumans, and philosophies that are always already sidelined from this public due to a historically and culturally particular European predilection for sovereignty?
My argument is that we need to maintain a role for the constitution, for these articulations of publicness, but that because it is a legal document that necessary delineates, necessarily cuts, it cannot also be the device that interrupts imaginations of sovereignty.
The constitution cannot simultaneously delimit and offer reflexivity upon that closure; it is not structurally designed for this purpose.
Surely, some will retort that all representation delineates, that all institutionalization is necessarily reductionist.
It is my view, however, that not all institutions are equally reductive. Where the constitution must, the museum can do otherwise. The museum is not structurally bound to offer the same neat story of sovereignty.
Countless annual school trips from elementary to college age often integrated with state-legislated curriculum , as well as tourist visits promoted by municipal, state, and federal governments, mean that the museum is a vibrant venue for thinking about popular conceptions of community but also a locus for effectively interrupting those conceptions.
While other sites might also serve as productive places from which sovereign imaginations of community can be disturbed, I retain a focus on the museum precisely because of its place as a common and quasi-official authorizer of truth.
This project thus takes seriously the question of being-in-common in the ontological realm, but only as it has ramifications for the ontic.
In this vein, my argument seems more akin to an Arendtian one: critique sovereignty, yes, but hold on to some semblance of order, or, in her words, promises in a sea of insecurity.
Constitutions are here now and not going anywhere quickly. The challenge then, I argue, is to simultaneously use them, acknowledge the hold they have on our collective imaginations as the pinnacle devices with which we organize society, and to disrupt that grip.
This is not a flippant dismissal of these lauded documents but rather a passionate concern with the ways in which constitutional precepts actively condition horizons of legal and political intelligibility.
If we want to imagine differently, I argue, we must confront our attachment to these documents and their imported language, subject, jurisdiction, and remedies.
This is a difficult argument to hold together; the first three chapters develop a critique of the constitution, while the latter two endorse its continued role in the contemporary moment.
I demonstrate in those early chapters the extent and significance of the limits of representation in the project of transformation. Chapter 1 introduces the tension between politics and the political by turning to political theorists and philosophers who have commented on the distinction over the course of the past century.
Significantly, this tension has animated much of the theory concerned with themes of freedom, sovereignty, and community. These thinkers, such as Schmitt and Arendt, are also concerned with a thinking of constitutionalism, its role, its potential, and its limitations.
Indeed, the tension between politics and the political animates much of constitutional thought, as scholars attempt to pair expansive notions of freedom with the limits imposed on this freedom by law.
Contemporary constitutional thinkers Martin Loughlin, Neil Walker, and Emilios Christodoulidis also attempt to address this tension.
Each specifically acknowledges the limits of the constitution and then attempts to address this limitation through the constitutional arrangement itself or by turning to the politics of civil society.
Both of these moves, however, remain focused on the production of community with the liberal individual subject at its center, when what is needed is a constitutionalism that can write the interruption of community.
Chapter 2 explores how the theme of community persists through the rise of the modern museum, as well as in calls for its reform.
Like the constitutionalism articulated by scholars in chapter 1, these orientations function to close down the world rather than open it up.
Retreating the political means reapproaching these assumptions in order to more fully attend to their limits and to contemplate more expansive conceptions of the new, democratic museum.
In the case of constitutionalism, the notion of enduring time lends legitimacy to the authority of the state.
In the case of the museum, chronological time is used to produce categories of community and the individual. In both cases, self-assured conceptions of past, present, and future are used to legitimize a narrow concept of the political.
Yet these anamorphic orientations cannot entirely smooth and cohere the world. Indeed, my research at the British Museum also yields examples of unexpected confusion, miscommunication, and frustration between staff members and participants that interrupt the anamorphic proclivities of the museum.
But although these sporadic events offer momentary contestations to the authority of chronological time, they do not go far enough in articulating the interruption of community.
Chapter 4 demonstrates that articulating the interruption of community can take place through countermonumental memorializing practices at the museum.
Although the museum, like the constitution, attempts to smooth the world through frameworks of sovereignty, there are also ways for it to resist this tendency.
Countermonumental practices, such as those observed through the interactive adult educational programming at the District Six Museum, intentionally disrupt the cohering of community.
And these practices have real ramifications for constitutionalism. Christodoulidis, a key critic of constitutional fetishism, looks to the potential of civil society to challenge the limits of the constitutional framework.
He argues that the powers of civil society, organized into a collective subject, offer the possibility of resistance. But while Christodoulidis engages in a critique of constitutional monumentalism, he ultimately endorses a monumental politics, one that hinges on the absolute immanence of the multitude that he derives from the work of Antonio Negri.
Rather than function in contradistinction to constitutionalism, a theory of politics motivated by a collective subject falls prey to the same dilemma of producing community.
Chapter 5 draws on existing South African constitutional theory to fully articulate a theory of countermonumental constitutionalism.
Here I explicitly build on the work already done by South African constitutional theorists that introduced the term in the s. My approach works with the continued existence of the constitutional arrangement but adds a crucial reflexive resource to it: the site of the museum.
I draw out this theory in relation to two recently postulated theories of jurisprudence. These theories, proffered by van der Walt and by Cornell and Muvangua, attempt to take seriously the contemporary constitutional arrangement in South Africa.
In response, they strive to make innovative additions to the existing adjudicational structure in the hopes of inspiring more just constitutional decisions in the future.
Although both theories are valiant attempts at negotiating the stifling proclivities of the constitution, they do not go far enough in attending to legacies of colonialism and apartheid.
This is because both center the constitutional arrangement as the key tool with which to inaugurate a postapartheid jurisprudence and therefore miss the opportunity to interrupt the logic of community.
A countermonumental constitutionalism that embraces the role of the museum builds on these theories to better attend to their projects of creating a postapartheid jurisprudence.
Museums are like constitutions in that they both share a proclivity to produce community. While this project of representation may be important and indeed necessary issues returned to in chapters 4 and 5 , this proclivity to produce community confuses representation with democracy.
In other words, the museum and the constitution conflate their projects of representation with the vast realities of existence, including nonsovereign conceptions of the individual and communities.
Constitutions and museums, if they embrace countermonumental memorializing practices, can attend to this need, reminding us of this reality.
Rather than exalt either the museum or the constitution as the central device with which to navigate complex questions of community, this book argues that it is the critical use of both that proffers positive possibilities.
The pairing of constitutions and museums provides a theory of postcolonial transformation that resists the persistent imaginations of sovereign individuals and sovereign communities.
Indeed, their pairing has the potential to offer a reflexive resource to the structural limitations of the constitution.
In so doing, museums and constitutions can be brought together to produce a countermonumental constitutionalism that disrupts the centrality of the constitution as the key site for the production of political community and takes the interruption of stable and secure notions of community as its task.
This alternative approach offers a new way to address the limits of conventional constitutionalism while attending to the complex demands of memory and community in the face of colonialism, apartheid, and other structural forms of inequity.
In response, they resuscitate respective notions of the political to attend to the crisis. Rather than see its subjugation to the already existing categories of everyday politics, Nancy sees the political as a necessary process of opening up conceptions of community.
Similarly, Martin Loughlin, Neil Walker, and Emilios Christodoulidis are three thinkers that engage in sustained debates about the role of constitutionalism in the production of political community.
Indeed, they all also note the distinction between politics and the political. Like the anamorphic orientations of the museum, what is missed in this predilection is a rethinking of the political at a distance from these concerns.
Indeed, what are constitutional theorists to do if not theorize about the role of the constitution? While a reconsideration of the political may cast doubts and concerns about this founding of political community, it does not necessarily result in its total rejection.
My challenge to the grounds of constitutional theory is thus not a withdrawal from making normative judgments.
The Concept of the Political Writing in the first half of the twentieth century, former Nazi and German jurist Carl Schmitt takes aim at the contemporary concept of the political.
There must no longer be political problems, only organizational-technical and economic-sociological tasks.
The kind of economic-technical thinking that prevails today is no longer capable of perceiving a political idea. The modern state seems to have actually become what Max Weber envisioned: a huge industrial plant.
Schmitt outlines his own concept of the political as the essential distinction between friend and enemy.
It is specifically a public distinction, one that encourages a division among humans into two opposing forces, rather than a private hatred. This allows for the concept of the political to be drawn and redrawn in any given moment.
He is merely critical of the evacuation of the political by the liberal democratic state that shrinks away from its fundamental reliance on the sovereign decision.
Arendt critiques what she sees as the blurring of the distinction between the political and the social. Drawing on Ancient Greek history and philosophy, she argues that the political must be a sphere privileged unto itself.
Rather, the private realm and its provision of biological necessities provide the very possibility of the political. For her, this conflation begins with the advent of the modern nation-state.
According to Arendt, eighteenth-century political thought collapsed the notion of freedom into that of the human will.
This silent substitution then formed the basis for the advent of a definition of freedom far from that found in her exalted polis. Rather, this shift founded freedom in sovereignty: Because of the shift from action to will-power, from freedom as a state of being manifest in action to the liberum arbitrium, the idea of freedom ceased to be virtuosity in the sense we mentioned before and became sovereignty, the ideal of a free will, independent from others and eventually prevailing against them.
She claims that these projects for popular sovereignty all too often took the form of a perverted form of the political, which secured citizens against tyrannical abuses but proffered no positive theory for political community.
It is the role of the promise, combined with an emphasis on collective deliberation, she claims, that animated the American Revolution and ensured its resistance to institutional sedimentation.
For Arendt, people need infrastructure within which the political can take place. Arendt draws on her fundamental theory of action to carve out a concept of the political that promotes public debate among humans.
Her emphasis on a properly public sphere and its concomitant human deliberators, however, continues to set the production of a world of the political as her task.
Arendt ultimately grounds her expansive conception of human plurality in her theory of politics. Rather than allow her antifoundational observations on the tyranny of sovereignty and the limits of constitutionalism to debilitate the very possibility of political community, she uses them to insert a safety valve that allows for the positive articulation of politics.
It illuminates the dangers of creating a political world and encourages a retreatment of the political beyond the consideration of humans and promises.
In order to counter this exposure to another thing, in order for the absolute to be absolute, it must enclose itself with another closure, thereby defeating the possibility of its absoluteness.
Consequently, the absolute is a contradiction. The separate enclosure is impossible as a result of a lack of any definitive boundary between inside and outside; there is only the relation of exposure.
Being-in-common is empty of any foundations based on a subject or a knowable, immanent community.
It is a sharing between beings, the sharing of the inside and outside. It is the necessary sharing of existence, of being-in-common.
Completed sharing would mean the annihilation of the space beyond the self that sets being in relation, and a denial of this space returns us to the mythical presupposition of representation.
Community is not a completed work but rather is an inoperative and incomplete sharing that we are abandoned to. It is the immediate being-there or immanence of myth.
Such a consciousness is incompatible with the myth of foundations or absolute immanence; it interrupts this myth by denying the positing of its completion.